In metabolic diseases, lean adipose tissue macrophage-derived exosomes (ExosLean) deliver miR-222-3p to target the inflammatory factor Bcl2l11/Bim, promoting macrophage polarization toward a reparative M2 phenotype in diabetic wounds and accelerating tissue healing (303). This evidence concerns the gene BCL2L11 and metabolic disease.